Finance ForgeBETA
Crear cuenta gratis
1)Empresas2)Rankings3)Iniciar sesión
Finance Forge Terminal v1.51.3
PrivacidadTérminosCookiesAviso Legal
● Connected
FMS US Equity
Fresenius Medical Care AG
21.08USD▼ 0.61%
Healthcare
Medical Care Facilities
96)Comparar97)Tesis →
Market Cap
$11.2B
Shares Outstanding
532M
EV/EBITDA
5.2×
— Annual —FY2016
Revenue
$17.9B
Gross Margin
32.3%
Operating Margin
14.7%
Net Margin
6.9%
FCF Margin
6.2%
ROE
11.5%
ROCE
12.1%
Net Debt/EBITDA
1.9×
Current Ratio
1.45
D/E Ratio
0.67
Dividend Yield
2.5%
FCF / Share
2.09
Book Value / Share
20.31
FMS US Equity
21.08USD▼ 0.61%
Tesis →

Fresenius Medical Care AG (FMS): análisis fundamental y valoración

Fresenius Medical Care AG cotiza a 21.08 USD y tiene una capitalización bursátil de $11.2B. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud

Price History
Loading...
Perfil
BolsaNYSEPaísGermanyEmpleados107,226Beta0.81Web↗ www.freseniusmedicalcare.com

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient…

Múltiplos de Valoración
P/E (Annual)
9.0×
P/E (TTM)
—
P/FCF (Annual)
10.1×
P/FCF (TTM)
—
EV/EBITDA
5.2×
EV/Revenue
1.0×
P/Sales
0.6×
P/Book
1.0×
Rentabilidad (Último Anual)
Gross Margin
32.3%
Operating Margin
14.7%
Net Margin
6.9%
FCF Margin
6.2%
ROE
11.5%
ROCE
12.1%
ROA
4.6%
Effective Tax Rate
44.3%
Métricas TTM
Revenue TTM
—
Gross Profit TTM
—
Operating Income TTM
—
Net Income TTM
—
FCF TTM
—
EPS TTM
—
Quarters Used
—
TTM Period
—
Solidez del Balance
Net Debt
$6.5B
Net Debt / EBITDA
1.9×
Debt / Equity
0.67
Current Ratio
1.45
Interest Coverage
5.8×
Working Capital
$2.3B
Book Value / Share
20.31
Net Debt / Share
12.13
Crecimiento (YoY)
Revenue YoY
+7.0%
Net Income YoY
+20.8%
FCF YoY
+10.2%
EPS Diluted YoY
+20.1%
Retorno al Accionista
Dividend Yield
2.5%
Payout Ratio
22.3%
FCF / Share
2.09
CapEx % Revenue
5.8%
Rev / Employee
167,037
Próximos Eventos
Ex-Dividendo
2026-05-22
Pago Dividendo
2026-06-08
Historial EPS
Periodo2026-112026-082026-052026-02
Real—$0.56$0.46$0.72
Estimado$0.51$0.50$0.50$0.55
Sorpresa—+12.0%-8.0%+30.9%
Empresas similares
Smart Money
vs Sector: Healthcare (1130 empresas)
MétricaFMSMediana SectorΔ
Gross Margin32.3%57.0%-24.8%
Operating Margin14.7%-38.6%+53.3%
Net Margin6.9%-33.6%+40.5%
FCF Margin6.2%-13.9%+20.1%
ROE11.5%-40.4%+51.9%
ROA4.6%-32.0%+36.6%
Current Ratio1.452.84-1.39
Debt / Equity0.670.28+0.39
Scoring Fundamental
Piotroski F-Score
7/ 9Moderado
✓F1ROA positivo (rentabilidad activos)
✓F2Flujo caja operativo positivo
✓F3ROA mejora vs año anterior
✓F4Calidad de beneficios (OCF > ROA)
✓F5Apalancamiento baja
✗F6Liquidez mejora (current ratio)
✗F7Sin dilución accionarial
✓F8Margen bruto mejora
✓F9Rotación activos mejora
Altman Z-ScoreZona Gris
2.02
x1_working_capital0.085
x2_retained_earnings0.328
x3_ebit0.098
x4_market_equity0.788
x5_sales0.665
>2.99 segura · 1.81–2.99 gris · <1.81 riesgo
Capital Allocation
6/ 8Sólida
✓FCF+Free cash flow positivo
✗FCFmMargen FCF > 10%
✓DilucSin dilución significativa (< 2%/año en 3 años)
✓Rev↑Revenue CAGR 3 años > 5%
✓ROCERetorno sobre capital empleado > 10%
✓DeudaDeuda neta/EBITDA < 3× (o posición de caja neta)
✗Mg↑Margen operativo ≥ hace 2-3 años (tolerancia -2pp)
✓Inv.R&D + Capex > 3% de revenue (reinversión en el negocio)
Histórico Piotroski F-Score
Histórico de Múltiplos